SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-015419
Filing Date
2022-05-31
Accepted
2022-05-31 06:12:11
Documents
12
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 20015
2 ex99-1.htm EX-99.1 1409282
3 ex99-2.htm EX-99.2 2833
4 ex99-3.htm EX-99.3 2990
5 ex99-1_001.jpg GRAPHIC 8666
6 ex99-1_002.jpg GRAPHIC 4705
7 ex99-1_003.jpg GRAPHIC 53998
8 ex99-1_004.jpg GRAPHIC 8666
9 ex99-2_001.jpg GRAPHIC 647154
10 ex99-2_002.jpg GRAPHIC 477765
11 ex99-3_001.jpg GRAPHIC 761471
12 ex99-3_002.jpg GRAPHIC 568694
  Complete submission text file 0001493152-22-015419.txt   4922327
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 22980305
SIC: 2834 Pharmaceutical Preparations